|
We asked 40 pharma professionals, What is the biggest threat to industry in the
next five years
| Lack of innovation |
59% |
| Poor pricing and uptake |
22% |
| Regulation |
16% |
| Generic competition |
3% |
 |
|
|
|
|
|
|
|
14 January, 2014
|
|
|
EU Clinical Trials Questions Still Unanswered
As well as Europe's clinical trials rules hanging in the balance as Europe shifts to 2014, there are other issues of equal importance that have been left unresolved, writes Peter O' Donnell ...View here |
Biolectronics: The Pulsing Pharmaceutical
New promise lies in approaches that rely on the “other language of biology,” using the human body’s own circuitry of cells and nerves to induce precisely targeted therapeutic effects against a range of debilitating diseases. William Looney reports ... Read more
|
What is the iPad's Future in Pharma?
Three years into the Apple-led tablet era, the iPad is still being used as no more than a glorified touchscreen. Gabriel Cangiano, Ron Kane, and David Windhausen look at the key role it can play in the future of pharma ... Read more
|
Trends That Will Shape the Industry in 2014
According to Pharm Exec Board member and investment analyst Les Funtleyder, three themes will dominate 2014. The first is a big strategic question; second, the prospect for more upside potential in biotech; and third, the glare of transparency that can no longer be ignored ... Read more
|
|
| Sciformix |
 Scignal Plus: Taking the Noise Out of Signal Detection
Scignal Plus provides superior, efficient signal detection by incorporating computational algorithms for a new method and previously known methods of signal detection. It has several distinct and important advantages over other products that are available in the market.  Read more. |
|
|
|
|
|
|
|
|
